Reuters logo
8 months ago
BRIEF-Editas Medicine says exclusively licensed intellectual property related to new CRISPR Technologies
December 19, 2016 / 12:13 PM / 8 months ago

BRIEF-Editas Medicine says exclusively licensed intellectual property related to new CRISPR Technologies

Dec 19 (Reuters) - Editas Medicine Inc

* Editas medicine inc - exclusively licensed intellectual property related to new crispr technologies

* Editas medicine - under terms co will make upfront cash payments of $6.25 million, issue promissory note totaling $10 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below